Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor

Recently a thrombin receptor with a unique mechanism of activation was cloned from a megakaryocyte-like cell line (Vu et al., Cell 64 :1057–1068, 1991). Thrombin cleaves a portion of this receptor creating a new N-terminus that acts as a “tethered-ligand” to activate the receptor. A thrombin recepto...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 1991-12, Vol.181 (2), p.636-643
Hauptverfasser: Seiler, Steven M., Goldenberg, Harold J., Michel, Inge M., Hunt, John T., Zavoico, George B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 643
container_issue 2
container_start_page 636
container_title Biochemical and biophysical research communications
container_volume 181
creator Seiler, Steven M.
Goldenberg, Harold J.
Michel, Inge M.
Hunt, John T.
Zavoico, George B.
description Recently a thrombin receptor with a unique mechanism of activation was cloned from a megakaryocyte-like cell line (Vu et al., Cell 64 :1057–1068, 1991). Thrombin cleaves a portion of this receptor creating a new N-terminus that acts as a “tethered-ligand” to activate the receptor. A thrombin receptor activating peptide (SFLLRNPNDKYEPF) homologous to the new N-terminus was shown to activate platelets. We synthesized this peptide and demonstrated that it desensitized platelets to activation by low concentrations of α-thrombin but not γ-thrombin. We also synthesized a thrombin exosite inhibitor (BMS 180742) that inhibited platelet aggregation induced by low, but not high, concentrations of α-thrombin. In contrast, a thrombin active site inhibitor, Nα-(2-naphthylsulfonyl-glycyl)-D,L-amidinophenylalanylpiperidide, competitively inhibited thrombin-induced platelet aggregation. We conclude that thrombin-induced platelet activation is mediated by at least two pathways: one activated by low concentrations of α-thrombin and blocked by a thrombin exosite inhibitor that appears to be coupled to the “tethered-ligand” thrombin receptor, and another that is stimulated by higher concentrations of α-thrombin and by γ-thrombin and does not require the thrombin exosite for activation. Both pathways are blocked by a thrombin active site inhibitor.
doi_str_mv 10.1016/0006-291X(91)91238-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72573915</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0006291X91912388</els_id><sourcerecordid>72573915</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-dec0ca130b32319e673493bc06646a9c5a10689db48a9d5bf16bb4d3961b75c23</originalsourceid><addsrcrecordid>eNp9kE2r1DAUhoMo1_HqP1DIQkQX1ZymTZvNBbn4BVfcKLgL-ThljnTSMUmvjvjj7dhh3Lk6i_d5Xw4PY49BvAQB6pUQQlW1hq_PNbzQUMu-6u-wDQgtqhpEc5dtzsh99iDnb0IANEpfsAvo2rZvug37_XEeC-1H5Htbtj_sIfNp4GWbpp2jWFEMs8fA96MtOGLh1he6tYWmyAMNAyaMhZYscHfgATPGTIV-rYSNgdvzGMef0xIip7glR2VKD9m9wY4ZH53uJfvy9s3n6_fVzad3H65f31Re9qpUAb3wFqRwspagUXWy0dJ5oVSjrPatBaF6HVzTWx1aN4ByrglSK3Bd62t5yZ6tu_s0fZ8xF7Oj7HEcbcRpzqar205qaBewWUGfppwTDmafaGfTwYAwR-nmaNQcjRoN5q900y-1J6f92e0w_Cutlpf86Sm32dtxSDZ6ymesFa3omuObVyuGi4tbwmSyJ4yLf0roiwkT_f-PP4ZDoO4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72573915</pqid></control><display><type>article</type><title>Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Seiler, Steven M. ; Goldenberg, Harold J. ; Michel, Inge M. ; Hunt, John T. ; Zavoico, George B.</creator><creatorcontrib>Seiler, Steven M. ; Goldenberg, Harold J. ; Michel, Inge M. ; Hunt, John T. ; Zavoico, George B.</creatorcontrib><description>Recently a thrombin receptor with a unique mechanism of activation was cloned from a megakaryocyte-like cell line (Vu et al., Cell 64 :1057–1068, 1991). Thrombin cleaves a portion of this receptor creating a new N-terminus that acts as a “tethered-ligand” to activate the receptor. A thrombin receptor activating peptide (SFLLRNPNDKYEPF) homologous to the new N-terminus was shown to activate platelets. We synthesized this peptide and demonstrated that it desensitized platelets to activation by low concentrations of α-thrombin but not γ-thrombin. We also synthesized a thrombin exosite inhibitor (BMS 180742) that inhibited platelet aggregation induced by low, but not high, concentrations of α-thrombin. In contrast, a thrombin active site inhibitor, Nα-(2-naphthylsulfonyl-glycyl)-D,L-amidinophenylalanylpiperidide, competitively inhibited thrombin-induced platelet aggregation. We conclude that thrombin-induced platelet activation is mediated by at least two pathways: one activated by low concentrations of α-thrombin and blocked by a thrombin exosite inhibitor that appears to be coupled to the “tethered-ligand” thrombin receptor, and another that is stimulated by higher concentrations of α-thrombin and by γ-thrombin and does not require the thrombin exosite for activation. Both pathways are blocked by a thrombin active site inhibitor.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/0006-291X(91)91238-8</identifier><identifier>PMID: 1755847</identifier><identifier>CODEN: BBRCA9</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Amino Acid Sequence ; Biological and medical sciences ; Blood coagulation. Blood cells ; Drug Tolerance ; Fundamental and applied biological sciences. Psychology ; Humans ; Molecular and cellular biology ; Molecular Sequence Data ; Peptide Fragments - chemistry ; Peptide Fragments - pharmacology ; Peptides - pharmacology ; Platelet ; Platelet Activation - drug effects ; Signal Transduction ; Thrombin - antagonists &amp; inhibitors ; Thrombin - pharmacology</subject><ispartof>Biochemical and biophysical research communications, 1991-12, Vol.181 (2), p.636-643</ispartof><rights>1991</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-dec0ca130b32319e673493bc06646a9c5a10689db48a9d5bf16bb4d3961b75c23</citedby><cites>FETCH-LOGICAL-c386t-dec0ca130b32319e673493bc06646a9c5a10689db48a9d5bf16bb4d3961b75c23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0006291X91912388$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5050742$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1755847$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Seiler, Steven M.</creatorcontrib><creatorcontrib>Goldenberg, Harold J.</creatorcontrib><creatorcontrib>Michel, Inge M.</creatorcontrib><creatorcontrib>Hunt, John T.</creatorcontrib><creatorcontrib>Zavoico, George B.</creatorcontrib><title>Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Recently a thrombin receptor with a unique mechanism of activation was cloned from a megakaryocyte-like cell line (Vu et al., Cell 64 :1057–1068, 1991). Thrombin cleaves a portion of this receptor creating a new N-terminus that acts as a “tethered-ligand” to activate the receptor. A thrombin receptor activating peptide (SFLLRNPNDKYEPF) homologous to the new N-terminus was shown to activate platelets. We synthesized this peptide and demonstrated that it desensitized platelets to activation by low concentrations of α-thrombin but not γ-thrombin. We also synthesized a thrombin exosite inhibitor (BMS 180742) that inhibited platelet aggregation induced by low, but not high, concentrations of α-thrombin. In contrast, a thrombin active site inhibitor, Nα-(2-naphthylsulfonyl-glycyl)-D,L-amidinophenylalanylpiperidide, competitively inhibited thrombin-induced platelet aggregation. We conclude that thrombin-induced platelet activation is mediated by at least two pathways: one activated by low concentrations of α-thrombin and blocked by a thrombin exosite inhibitor that appears to be coupled to the “tethered-ligand” thrombin receptor, and another that is stimulated by higher concentrations of α-thrombin and by γ-thrombin and does not require the thrombin exosite for activation. Both pathways are blocked by a thrombin active site inhibitor.</description><subject>Amino Acid Sequence</subject><subject>Biological and medical sciences</subject><subject>Blood coagulation. Blood cells</subject><subject>Drug Tolerance</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Molecular and cellular biology</subject><subject>Molecular Sequence Data</subject><subject>Peptide Fragments - chemistry</subject><subject>Peptide Fragments - pharmacology</subject><subject>Peptides - pharmacology</subject><subject>Platelet</subject><subject>Platelet Activation - drug effects</subject><subject>Signal Transduction</subject><subject>Thrombin - antagonists &amp; inhibitors</subject><subject>Thrombin - pharmacology</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE2r1DAUhoMo1_HqP1DIQkQX1ZymTZvNBbn4BVfcKLgL-ThljnTSMUmvjvjj7dhh3Lk6i_d5Xw4PY49BvAQB6pUQQlW1hq_PNbzQUMu-6u-wDQgtqhpEc5dtzsh99iDnb0IANEpfsAvo2rZvug37_XEeC-1H5Htbtj_sIfNp4GWbpp2jWFEMs8fA96MtOGLh1he6tYWmyAMNAyaMhZYscHfgATPGTIV-rYSNgdvzGMef0xIip7glR2VKD9m9wY4ZH53uJfvy9s3n6_fVzad3H65f31Re9qpUAb3wFqRwspagUXWy0dJ5oVSjrPatBaF6HVzTWx1aN4ByrglSK3Bd62t5yZ6tu_s0fZ8xF7Oj7HEcbcRpzqar205qaBewWUGfppwTDmafaGfTwYAwR-nmaNQcjRoN5q900y-1J6f92e0w_Cutlpf86Sm32dtxSDZ6ymesFa3omuObVyuGi4tbwmSyJ4yLf0roiwkT_f-PP4ZDoO4</recordid><startdate>19911216</startdate><enddate>19911216</enddate><creator>Seiler, Steven M.</creator><creator>Goldenberg, Harold J.</creator><creator>Michel, Inge M.</creator><creator>Hunt, John T.</creator><creator>Zavoico, George B.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19911216</creationdate><title>Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor</title><author>Seiler, Steven M. ; Goldenberg, Harold J. ; Michel, Inge M. ; Hunt, John T. ; Zavoico, George B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-dec0ca130b32319e673493bc06646a9c5a10689db48a9d5bf16bb4d3961b75c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Amino Acid Sequence</topic><topic>Biological and medical sciences</topic><topic>Blood coagulation. Blood cells</topic><topic>Drug Tolerance</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Molecular and cellular biology</topic><topic>Molecular Sequence Data</topic><topic>Peptide Fragments - chemistry</topic><topic>Peptide Fragments - pharmacology</topic><topic>Peptides - pharmacology</topic><topic>Platelet</topic><topic>Platelet Activation - drug effects</topic><topic>Signal Transduction</topic><topic>Thrombin - antagonists &amp; inhibitors</topic><topic>Thrombin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seiler, Steven M.</creatorcontrib><creatorcontrib>Goldenberg, Harold J.</creatorcontrib><creatorcontrib>Michel, Inge M.</creatorcontrib><creatorcontrib>Hunt, John T.</creatorcontrib><creatorcontrib>Zavoico, George B.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seiler, Steven M.</au><au>Goldenberg, Harold J.</au><au>Michel, Inge M.</au><au>Hunt, John T.</au><au>Zavoico, George B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>1991-12-16</date><risdate>1991</risdate><volume>181</volume><issue>2</issue><spage>636</spage><epage>643</epage><pages>636-643</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><coden>BBRCA9</coden><abstract>Recently a thrombin receptor with a unique mechanism of activation was cloned from a megakaryocyte-like cell line (Vu et al., Cell 64 :1057–1068, 1991). Thrombin cleaves a portion of this receptor creating a new N-terminus that acts as a “tethered-ligand” to activate the receptor. A thrombin receptor activating peptide (SFLLRNPNDKYEPF) homologous to the new N-terminus was shown to activate platelets. We synthesized this peptide and demonstrated that it desensitized platelets to activation by low concentrations of α-thrombin but not γ-thrombin. We also synthesized a thrombin exosite inhibitor (BMS 180742) that inhibited platelet aggregation induced by low, but not high, concentrations of α-thrombin. In contrast, a thrombin active site inhibitor, Nα-(2-naphthylsulfonyl-glycyl)-D,L-amidinophenylalanylpiperidide, competitively inhibited thrombin-induced platelet aggregation. We conclude that thrombin-induced platelet activation is mediated by at least two pathways: one activated by low concentrations of α-thrombin and blocked by a thrombin exosite inhibitor that appears to be coupled to the “tethered-ligand” thrombin receptor, and another that is stimulated by higher concentrations of α-thrombin and by γ-thrombin and does not require the thrombin exosite for activation. Both pathways are blocked by a thrombin active site inhibitor.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>1755847</pmid><doi>10.1016/0006-291X(91)91238-8</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 1991-12, Vol.181 (2), p.636-643
issn 0006-291X
1090-2104
language eng
recordid cdi_proquest_miscellaneous_72573915
source MEDLINE; Elsevier ScienceDirect Journals
subjects Amino Acid Sequence
Biological and medical sciences
Blood coagulation. Blood cells
Drug Tolerance
Fundamental and applied biological sciences. Psychology
Humans
Molecular and cellular biology
Molecular Sequence Data
Peptide Fragments - chemistry
Peptide Fragments - pharmacology
Peptides - pharmacology
Platelet
Platelet Activation - drug effects
Signal Transduction
Thrombin - antagonists & inhibitors
Thrombin - pharmacology
title Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T10%3A20%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20pathways%20of%20thrombin-induced%20platelet%20activation%20differentiated%20by%20desensitization%20and%20a%20thrombin%20exosite%20inhibitor&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Seiler,%20Steven%20M.&rft.date=1991-12-16&rft.volume=181&rft.issue=2&rft.spage=636&rft.epage=643&rft.pages=636-643&rft.issn=0006-291X&rft.eissn=1090-2104&rft.coden=BBRCA9&rft_id=info:doi/10.1016/0006-291X(91)91238-8&rft_dat=%3Cproquest_cross%3E72573915%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72573915&rft_id=info:pmid/1755847&rft_els_id=0006291X91912388&rfr_iscdi=true